Leerink Partners upgraded Sanofi-Aventis (NYSE: SNY) from Market Perform to Outperform and raised their price target from EUR 85 to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE